TY - JOUR
T1 - Two cases with generalised bullous cutaneous reactions after COVID-19 mRNA vaccine Moderna (Spikevax®) and Pfizer–BioNTech (Comirnaty®)
AU - Rinnooy Kan, Charlotte E.
AU - Röckmann, Heike
AU - van Dijk, Marijke R.
AU - Ramsaransing, Tanuja
AU - Reubsaet, Lieke L.
AU - Peters, Elke E.M.
AU - Vos, Lydia E.
N1 - Publisher Copyright:
© 2023 The Authors. JEADV Clinical Practice published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.
PY - 2024/3
Y1 - 2024/3
N2 - Bullous cutaneous reactions can be caused by many factors, including vaccines.1 However, among all cutaneous reactions following coronavirus disease 2019 (COVID-19) mRNA vaccines, bullous reactions are rare. Here, we describe two patients with delayed generalised bullous cutaneous reactions 7 days after receiving Moderna (Spikevax®) and Pfizer–BioNTech (Comirnaty®) COVID-19 vaccination, respectively.
AB - Bullous cutaneous reactions can be caused by many factors, including vaccines.1 However, among all cutaneous reactions following coronavirus disease 2019 (COVID-19) mRNA vaccines, bullous reactions are rare. Here, we describe two patients with delayed generalised bullous cutaneous reactions 7 days after receiving Moderna (Spikevax®) and Pfizer–BioNTech (Comirnaty®) COVID-19 vaccination, respectively.
KW - bullous cutaneous reaction
KW - bullous eruption
KW - COVID-19 mRNA vaccination
KW - Pfizer and Moderna COVID-19 vaccination
KW - reactive dermatitis
UR - http://www.scopus.com/inward/record.url?scp=85186435887&partnerID=8YFLogxK
U2 - 10.1002/jvc2.273
DO - 10.1002/jvc2.273
M3 - Article
AN - SCOPUS:85186435887
VL - 3
SP - 275
EP - 279
JO - JEADV Clinical Practice
JF - JEADV Clinical Practice
IS - 1
ER -